hrs4r
 I want to donate
Firma
DAVID BUSQUETS-CASALS
Position
Investigador/a Pre-doctoral – R1
Predoctoral Researchers – R1

Publicacions

0

Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease.

Frontiers in Immunology, 2022, 13, 748839-748839 dx.doi.org/10.3389/fimmu.2022.748839
0

Eradication of neoplastic Barrett's esophagus in patients with esophageal varices with a modified endoscopic mucosal resection technique and radiofrequency ablation.

Endoscopy, 2022, 54, 261-263 dx.doi.org/10.1055/a-1516-3400
0

Endoscopic full-thickness resection in the rectum closed with PolyLoop-and-clips method using single-channel endoscope.

Endoscopy, 2022, 54, 24-25 dx.doi.org/10.1055/a-1352-2356
0

Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.

Frontiers in Immunology, 2022, 13, 966184-966184 dx.doi.org/10.3389/fimmu.2022.966184
0

Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry.

JOURNAL OF CROHNS & COLITIS, 2022, 16, 946-953 dx.doi.org/10.1093/ecco-jcc/jjab213
0

Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.

DIGESTIVE AND LIVER DISEASE, 2022, 54, 635-641 dx.doi.org/10.1016/j.dld.2021.10.002
0

Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial.

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7, 332-341 dx.doi.org/10.1016/S2468-1253(21)00386-1
0

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.

GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45, 165-176 dx.doi.org/10.1016/j.gastrohep.2021.04.010

Chaparro M, Garre A, Mesonero F, Rodríguez C, Barreiro-de Acosta M, Martínez-Cadilla J, Arroyo MT, Manceñido N, Sierra-Ausín M, Vera-Mendoza I, Casanova MJ, Nos P, González-Muñoza C, Martínez T, Boscá-Watts M, Calafat M, Busquets D, Girona E, Llaó J, Martín-Arranz MD, Piqueras M, Ramos L, Surís G, Bermejo F, Carbajo AY, Casas-Deza D, Fernández-Clotet A, García MJ, Ginard D, Gutiérrez-Casbas A, Hernández L, Lucendo AJ, Márquez L, Merino-Ochoa O, Rancel FJ, Taxonera C, López Sanromán A, Rubio S, Domènech E, Gisbert JP

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.

JOURNAL OF CROHNS & COLITIS, 2021, 15, 35-42 dx.doi.org/10.1093/ecco-jcc/jjaa145

Oliveras B, Albert M, López C, Fort E, Peries L, Gutiérrez L, Busquets D, Uchima H, Aldeguer X, Piñol V

A case report of gastrointestinal histoplasmosis in a patient treated with infliximab.

Clinical Journal of Gastroenterology, 2021, 14, 690-692 dx.doi.org/10.1007/s12328-020-01298-y

Formulari de contacte

About IDIBGI!

menu